Apoptosis of intestinal crypt epithelium after Cryptosporidium parvum infection

Journal of Infection and Chemotherapy

Volumn 9, Issue 3, 2003, Pages 278-281

  Sasahara, Takeshi ^a   Maruyama, Hiroko ^b   Aoki, Masahito ^b   Kikuno, Ritsuko ^b   Sekiguchi, Tomoko ^a   Takahashi, Akira ^a   Satoh, Yoshinori ^a   Kitasato, Hidero ^a   Takayama, Yoko ^a   Inoue, Matsuhisa ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cryptosporidium parvum; Intestinal crypt epithelium

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CECUM; COLON; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DUODENUM; EPITHELIUM CELL; ILEUM; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE VILLUS; MOUSE; NONHUMAN; OOCYST; PROTOZOAL INFECTION; SMALL INTESTINE;

EID: 0142026519     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0259-1     Document Type: Article

References (15)

1. Ojcius DM, Perfettini J, Bonnin A, Laurent F. Caspase-dependent apoptosis during infection with Cryptosporidium parvum. Microbes Infect 1999;1:1163-8.
2. McCole DF, Eckmann L, Laurent F, Kagnoff MF. Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect Immun 2000;68:1710-3.
3. Joe A, Verdon R, Tzipori S, Keusch GT, Ward HD. Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. Infect Immun 1998;66:3429-32.
4. Phillips AD, Thomas AG, Walker-Smith JA. Cryptosporidium, chronic diarrhoea and the proximal small intestinal mucosa. Gut 1992;33:1057-61.
5. Goodgame RW, Kimball K, Ou C, White AC Jr, Genta RM, Lifschitz CH, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995;108:1075-82.
6. Griffiths JK, Moore R, Dooley S, Keusch GT, Tzipori S. Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Infect Immun 1994;62:4506-14.
7. Chen XM, Keithly JS, Paya CV, LaRusso NL. Cryptosporidiosis. N Engl J Med 2002;346:1723-31.
8. Abe N, Kimata I, Iseki M. Identification of genotypes of Cryptosporidium parvum isolates from a patient and a dog in Japan. J Vet Med Sci 2002;64:165-8.
9. Sasahara T, Aoki M, Sekiguchi T, Takahashi A, Satoh Y, Kitasato H, et al. Effect of the mixed-oxidant solution on infectivity of Cryptosporidium parvum oocysts in a neonatal mouse model. J Jpn Assoc Infect Dis 2003;77:75-82.
10. Current WL, Reese NC. A comparison of endogenous development in three isolates of Cryptosporidium in suckling mice. J Protozool 1986;33:98-108.
11. Vollenweider JM, Chen XM, Gores GJ, Paya CV, LaRusso NF. HIV-1-associated TAT protein enhances Cryptosporidium parvum-induced apoptosis in cultured human biliary epithelia Hepatology 2001;34:268A.
12. Watson AJM. Necrosis and apoptosis in the gastrointestinal tract. Gut 1995;37:165-7.
13. Ragland BD, Ashley LS, Vaux DL, Petri WA. Entamoeba histolytica: target cells killed by trophozoites undergo DNA fragmentation which is not blocked by Bcl-2. Exp Parasitol 1994;79:460-7.
14. Cosyns M, Tsirkin S, Jones M, Flavell R, Kikutani H, Hayward AR. Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidum parvum from mice. Infect Immun 1998;66:603-7.
15. Rouquet N, Pages JC, Molina T, Briand P, Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol 1996;6:1192-5.